Edition:
United States

Active Biotech AB (ACTI.ST)

ACTI.ST on Stockholm Stock Exchange

9.55SEK
2 Dec 2016
Change (% chg)

-- (--)
Prev Close
9.55kr
Open
9.75kr
Day's High
9.75kr
Day's Low
9.55kr
Volume
103,184
Avg. Vol
65,197
52-wk High
17.01kr
52-wk Low
7.37kr

ACTI.ST

Chart for ACTI.ST

About

Active Biotech AB is a Sweden-based company that focuses on pharmaceutical research and development in medical fields in which the immune system plays a central role. The Company’s research portfolio primarily includes projects for the development of drugs for the treatment of autoimmune and inflammatory diseases and cancer. As... (more)

Overall

Beta: 2.33
Market Cap(Mil.): kr987.61
Shares Outstanding(Mil.): 96.82
Dividend: --
Yield (%): --

Financials

  ACTI.ST Industry Sector
P/E (TTM): -- 42.21 29.87
EPS (TTM): -0.94 -- --
ROI: -20.62 -1.09 14.95
ROE: -42.75 -2.39 16.29

BRIEF-Active Biotech to raise SEK 55 mln via rights issue

* Active biotech carries out rights issue of approximately 55 million Swedish crowns ($6.03 million)

Nov 14 2016

BRIEF-Active Biotech Q3 loss narrows

* Cash and cash equivalents at the end of the period SEK 39.9 million Source text for Eikon: Further company coverage: (Reporting by Stockholm Newsroom)

Nov 14 2016

BRIEF-Active Biotech partners with NeoTX for commercialization of ANYARA

* Reg-Active Biotech and NeoTX enter into a partnership for the development and commercialization of ANYARA for immuno-oncology

Oct 26 2016

BRIEF-Active Biotech postpones publication of interim report

* Reg-Active Biotech postpone publication of the interim report

Oct 26 2016

BRIEF-Active Biotech updates on laquinimod development

* Active Biotech update on laquinimod development: U.S, Food and Drug Administration rescinds special protocol assessment for laquinimod Source text for Eikon: Further company coverage:

Sep 19 2016

Earnings vs. Estimates